Synapse - Mark Kris

Results (872)

FGFR1 amplification is associated with improved survival in patients with early-stage squamous cell carcinomas of the lung (SQCLC)

Meeting Abstract

Hellmann, M. D.; Wynne, M.; Wang, L.; Kris, M. G.; Sima, C. S.; Moreira, A. L.; Rekhtman, N.; Paik, P. K.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Tumor expression of TTF1 is associated with a doubling of overall survival in patients with advanced lung adenocarcinomas

Meeting Abstract

Hellmann, M. D.; Hilden, P. D.; Sima, C. S.; Kris, M. G.; Rekhtman, N.; Chaft, J. E.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

"Intention-to-treat" outcomes of sequential patients with stage IIIA lung adenocarcinomas treated with neoadjuvant chemotherapy with intent of surgical resection

Meeting Abstract

Hellmann, M. D.; Chaft, J. E.; Hilden, P. D.; Rusch, V. W.; Kris, M. G.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Ret fusion-positive advanced lung cancers: Response to first-line chemotherapy and survival in comparison to ROS1 and ALK fusion-positive and EGFR- and KRAS-mutant lung cancers

Meeting Abstract

Drilon, A.; Wang, L.; Joubert, P.; Snyder, A.; Cho, E. J.; Riely, G.; Kris, M.; Ladanyi, M.; Rizvi, N.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Major pathologic response (<= 10% viable tumor) following neoadjuvant chemotherapy as a surrogate for overall survival in patients with pathologically documented stage IIIA (N2) lung adenocarcinomas

Meeting Abstract

Chaft, J. E.; Hellmann, M. D.; Rusch, V. W.; Travis, W. D.; Kris, M. G.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

A phase II study of 18f-FDG PET guided optimization of neoadjuvant chemotherapy for resectable non-small cell lung cancer

Meeting Abstract

Chaft, J. E.; Hellmann, M. D.; Dunphy, M.; Jappe, W.; Sima, C. S.; Downey, R. J.; Travis, W. D.; Azzoli, C. G.; Kris, M. G.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Phase 2 study of the GI-4000 KRAS vaccine following curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, G12V or G12R mutation

Meeting Abstract

Chaft, J. E.; Arcila, M.; Patel, P.; Apelian, D. M.; Mattson, A.; Coeshott, C.; Kris, M. G.; Azzoli, C. G.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Feasibility of long-term patient self-reporting of toxicities from home via the internet during routine chemotherapy

Journal Article

Judson, T. J.; Bennett, A. V.; Rogak, L. J.; Sit, L.; Barz, A.; Kris, M. G.; Hudis, C. A.; Scher, H. I.; Sabbatini, P.; Schrag, D.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Anaplastic lymphoma kinase (ALK) positive central nervous system (CNS) metastases from non small cell lung cancer (NSCLC)

Meeting Abstract

Singer, S.; Riely, G. J.; Kris, M. G.; Grommes, C.
Neuro-Oncology (2013)

Fulltext@MSK | Save

Systemic bevacizumab (Bev) for leptomeningeal disease (LMD) from non-small cell lung cancer

Meeting Abstract

Carlo, M.; Omuro, A.; Grommes, C.; Kris, M.; Nolan, C.; Pentsova, E.; Pietanza, M.; Kaley, T.
Neuro-Oncology (2013)

Fulltext@MSK | Save